METHYL 2-((12,12-DIMETHYL-10-OXO-3,6,11-TRIOXA-9-AZATRIDEC-1-YL)OXY)-4-(3-(TRIFLUOROMETHYL)-3H-DIAZIRIN-3-YL)BENZOATE
UNII 25L8Y3R8NN
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl 2-((12,12-dimethyl-10-oxo-3,6,11-trioxa-9-azatridec-1-yl)oxy)-4-(3-(trifluoromethyl)-3h-diazirin-3-yl)benzoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 25L8Y3R8NN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 165963-73-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H28F3N3O7 LUZHOFLOLFEWPZ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl 2-((12,12-dimethyl-10-oxo-3,6,11-trioxa-9-azatridec-1-yl)oxy)-4-(3-(trifluoromethyl)-3h-diazirin-3-yl)benzoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.